Reimbursement
-
Butler funds new PBS options for patients
- Mon Sep 21
Two more listings announced for October, Arrotex securing funding for an eczema cream that will benefit an estimated 100,000 patients.
Read more -
‘We are going to have to be agile’: Butler
- Fri Sep 18
Desperate to fill the pending gap left by AZ’s Zoladex leaving the PBS, the government demonstrates how fast it can move when patient access is threatened.
Read more -
PBAC risks falling behind global HTA peers
- Wed Sep 16
Researchers compared PBAC to nine other leading HTA agencies, noting where Australia’s HTA agency stands out, and where it lags behind.
Read more -
PBAC harmony? That’s a matter of perspective
- Fri Sep 11
OP-ED: Broad funding of immunotherapies is a story of collaboration says Prof Robyn Ward, but given the time it took, is this really what success looks like?
Read more -
Targeted MND therapy gains fast PBS berth
- Fri Sep 11
Fast-tracked through TGA and PBS, the first therapy for a rare form of ALS is to be funded on the PBS four months after TGA registration.
Read more -
Funding meds in NZ would pay for itself: report
- Wed Sep 9
New analysis finds NZ would gain economic and fiscal returns by lifting medicines funding to OECD levels with benefits outweighing costs.
Read more -
How a PBAC ‘yes’ has become the new ‘no’
- Mon Sep 7
New analysis reveals positive PBAC decisions are rising, but workable listings aren’t signalling a PBAC ‘yes’ is no longer what it used to be.
Read more -
Expansions mark strong month for September PBS
- Wed Sep 2
Five of the eight changes to the PBS this month were pre-announced, but what else changed, and how are new listings tracking?
Read more